Halofuginone is a biologic that has been apparent to accept an antifibrotic acreage in vitro and in vivo.In accord with the lab of Dr Anjana Rao of the Immune Disease Institute, we accept apparent that HF selectively blocks the adverse of Th17 cells, a pro-inflammatory T corpuscle subtype acerb active in a array of animal autoimmune diseases.Whereas halofuginone shows affiance as a ameliorative abettor for a array of diseases including scleroderma, alarmist cirrhosis, cystic fibrosis, and assertive types of cancer, the apparatus of activity charcoal unknown. It has antimalarial and anticoccidial actions.
